Share on LinkedInShare on LinkedIn

ARTICLE · 26 MARCH 2014

USPTO Issues New Patent Subject Matter Eligibility Guidelines Under Myriad And Mayo Decisions

On March 4, 2014, the U.S. Patent and Trademark Office issued a long-awaited guidance memo for evaluating subject matter eligibility under 35 U.S.C § 101 in the wake of two recent Supreme Court decisions: Association for Molecular Pathology, et. al. v. Myriad Genetics, Inc., et. al.i and Mayo Collaborative Services, et. al. v. Prometheus Laboratories, Inc.ii This memorandum can be found here.

United StatesIntellectual Property

On March 4, 2014, the U.S. Patent and Trademark Office issued a long-awaited guidance memo for evaluating subject matter eligibility under 35 U.S.C § 101 in the wake of two recent Supreme Court decisions: Association for Molecular Pathology, et. al. v. Myriad Genetics, Inc., et. al.i and Mayo Collaborative Services, et. al. v. Prometheus Laboratories, Inc.ii This memorandum can be found here.  

The guidance memo broadly applies to all claims reciting or involving laws of nature/natural principles, natural phenomena, and/or natural products. According to the guidance memo, if a claim recites a law of nature/natural principle, a natural phenomenon, or a natural product, patent eligibility is determined by whether the claim as a whole recites something "significantly different" from the law of nature/natural principle, natural phenomena, or natural product. To assist examiners in making this determination, the guidance memo provides a multi-factor balancing test and a

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from